Infratril (ASX:IFT) share price up on acquisition bid

The Infratril share price has shot up on news of a potential 60% acquisition of Qscan, a medical diagnosis and imaging company.

| More on:
Santos Oil Search ASX share price movements represented by street signs stating mergers and acquisitions bluescope share price

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Infratil Ltd (ASX: IFT) share price is on the rise today after the company announced it plans to acquire up to 60% of Qscan Group Holdings Pty Ltd from Quadrant Private Equity. At the time of writing, the Infratil share price is up 2.66% to $5.40 after reaching as high as $5.55 in morning trade. The potential deal is for a total cash equity consideration of up to $330 million. Qscan is a comprehensive diagnostic imaging practice with locations throughout Australia. The Infratril share price is responding positively to an implied enterprise value (EV) to earnings before interest, taxes, depreciation and amortisation (EBITDA) of 12.7-14.1. 

What's moving the Infratril share price?

In June 2020, Infratil raised additional equity of NZ$300 million to pursue its growth agenda and take advantage of investment opportunities that may arise. This capital paid down bank facilities and, consequently, can be used to fund the Qscan acquisition, news of which is driving the Infratril share price higher today. Infratil has made the offer in conjunction with the Morrison & Co Growth Infrastructure Fund (MGIF), which has conditionally offered to acquire up to ~15% of Qscan.

Qscan grew from initially operating a single clinic and hospital contract. Today, it is a group operating a portfolio of 70+ clinics across Australia. This includes a network of 10 clinics offering Positron Emission Tomography (PET) in oncology.

The acquisition, if successful, will provide Infratril with a foothold in the very lucrative healthcare diagnostics and imaging sector. At present, the company has invested in defensive shares, such as Tilt Renewables Ltd (ASX: TLT). 

The Qscan investment will be managed by Morrison & Co on behalf of Infratril and MGIF. Moreover, it is conditional on doctor and management shareholders holding the equivalent of ~25% to 32.5% of the business post-close. This therefore requires reinvestment of some of the proceeds into the new holding vehicle. Furthermore, investors in the Infratril share price appear happy with the shared risk, and the diversification into medical imaging. 

Management commentary

Marko Bogoievski, CEO of Infratil said of the acquisition:

Qscan provides a high-quality entry point into a sector with structural long-term growth and potential to scale into a leading healthcare infrastructure platform…

The Diagnostic Imaging sector benefits from long-term demographic tailwinds and technological advances that will allow it to play a growing role in the early detection of diseases such as cancer. Ultimately, increased investment in Diagnostic Imaging will reduce overall healthcare system costs while improving patient outcomes.

Paul Newfield, head of Australia and New Zealand for Morrison & Co, commented:

Qscan is a market leader in a growth industry. It has a secure revenue base backed by strong referral networks. In addition, there is a track record of strong, profitable growth, with significant further growth potential, Qscan is also known for the quality of its Doctors and the strength of their sub-specialty expertise.

Motley Fool contributor Daryl Mather has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Stock market chart in green with a rising arrow symbolising a rising share price.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a massive day for the ASX 200, with a new all-time high recorded.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Technology Shares

This ASX tech stock rocketed 60% in March! Can it keep on delivering?

After soaring in March, the ASX tech stock is now up 169% since this time last year.

Read more »

Broker Notes

Brokers name 3 ASX shares to buy now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A young man clasps his hand to his head with his eyes closed and a pained expression on his face as he clasps a laptop computer in front of him, seemingly learning of bad news or a poor investment.
Share Fallers

Why Burgundy Diamond Mines, Clarity Pharmaceuticals, EML, and Zip are sinking today

These ASX shares are ending the week in the red. But why?

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Mesoblast, Newmont, Pilbara Minerals, and Platinum shares are jumping

These ASX shares are ending the week strongly. But why?

Read more »

a young boy dressed up in a business suit and tie has a cute grin and holds two fingers up.
Opinions

2 of my top ASX 200 shares to consider buying before April

I would happily exchange dollars for these two shares right now.

Read more »

Father in the ocean with his daughters, symbolising passive income.
Dividend Investing

I'd spend $8k on these ASX 200 shares today to target a $6,102 annual passive income

I believe these ASX 200 shares will continue rewarding passive income investors for years to come.

Read more »

Three businesspeople leap high with the CBD in the background.
Share Market News

Boom! ASX 200 blasts to new record highs

ASX 200 investors just sent the benchmark index into uncharted territory.

Read more »